News
End of the evaluation of the PHOSISTOS® project
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
Authorizations for the PAGETEX clinical trial
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
Translationnelles of the Cancéropole Nord-Ouest: First prize for the PDT
On November 8th and 9th, 2018, the Cancéropole Nord-Ouest organized the second edition of the "Translationnelles" days: "Ovarian cancer - from biology to clinic" in Caen, France.
Photodynamic Therapy and OncoThAI illustrated in Nature journal
The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal
Rare diseases foundation and OncoThAI
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
Enrollment phase of INDYGO is now successfully achieved
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
Special issue of the Lasers in Surgery and Medicine journal
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
The EAMBES elects a new member
Prof. Serge Mordon promoted Fellow of the European Alliance for Medical and Biological Engineering & Science
17th Annual Congress of the European Society for Photodynamic Therapy
OncoThAI will attend the 17th Congress of the European Society for Photodynamic Therapy in Nice, France On March 16th and 17th 2018.
Page 3 of 6
